Reversible Corpus Callosal Lesions Associated with the Use of Adalimumab for Ulcerative Colitis.
10.3988/jcn.2017.13.2.209
- Author:
Jin Woo PARK
1
;
Hung Yuol SEOK
;
Yoohwan KIM
;
Byung Jo KIM
Author Information
1. Department of Neurology, Korea University College of Medicine, Korea University Anam Hospital, Seoul, Korea. nukbj@korea.ac.kr
- Publication Type:Brief Communication
- MeSH:
Adalimumab*;
Colitis, Ulcerative*;
Ulcer*
- From:Journal of Clinical Neurology
2017;13(2):209-211
- CountryRepublic of Korea
- Language:English
-
Abstract:
No abstract available.
